Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Presented on .

The March session of Grand Rounds “Global Introduction of New Vaccines: Delivering More to More,” was viewed in 6 foreign countries and in 43 states, plus the District of Columbia.

Vaccinations save the lives of 2 to 3 million people every year, including children. Yet 1 child dies every 20 seconds from a disease that could have been prevented by a vaccine. Why? Because 1 in 5 children in the world do not have access to the life-saving immunizations that keep children healthy.

Join us for this session to find out how CDC and its global partners work together to protect people of all ages from life-threatening, vaccine-preventable diseases. Learn about regional and global outbreaks of new or emerging vaccine-preventable diseases, and hear about the successes and challenges of introducing new vaccines around the world.

Beyond the Data - Global Introduction of New Vaccines: Delivering More to More

CDC and its global partners work together to protect people of all ages from life-threatening, vaccine-preventable diseases. Dr. Phoebe Thorpe and Dr. Carsten Mantel discuss new vaccines and the successes and challenges of introducing new vaccines to communities and countries around the word. For more information on vaccines, visit these helpful websites:

Audience Questions

Will we the public be receiving full listing of ingredients and possible side effects with these new vaccines?

The public has access to vaccine information and a full list of ingredients for each US vaccine. The following links provide more information on specific vaccines and ingredients: Vaccine Safety and vaccine ingredients list.

In low-income countries, will the population be vaccinated gratuitously?

Vaccination is undoubtedly one of the most significant advances in public health. Both political and financial support is needed in order to sustain vaccination efforts in any country, which ultimately poses more challenges among low- and middle-income countries. This report by WHO reviews the estimated economic impact of vaccinations in low- and middle-income countries from 2001 - 2020 along with a case study on how new vaccines are prioritized in low-income countries.

Presented By

LCDR Anagha Loharikar, MD
Medical Officer
Vaccine Introduction Team
Immunization System Branch, Global Immunization Division
Center for Global Health, CDC
"Global Progress"
Carsten Mantel, MD, MPH
Senior Advisor Immunization
Department of Infectious Disease Epidemiology
Robert Koch Institute, Berlin
Managing Director
MM Global Health Consulting, GmbH, Zürich
"Country Implementation"
Craig Burgess, MD
Senior Technical Advisor
JSI Training and Research Institute, Inc.
"Financial and Economic Considerations"

Facilitated By

John Iskander, MD, MPH
Scientific Director
Phoebe Thorpe, MD, MPH
Deputy Scientific Director
Susan Laird, MSN, RN
Communications Director

Enjoyed this Presentation?

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!Sign Up

Sign Up

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

Continuing Education

This session is available for Continuing Education (CE). Register here using the course information below.

CDC Course Code: PHGR10
CPE UAN: 0387-0000-18-099-H04-P

For more information, see Grand Rounds Continuing Education.

  • Page last reviewed: April 4, 2018
  • Page last updated: June 21, 2018
  • Content source:
    • Office of the Associate Director for Science
    • Page maintained by: Office of the Associate Director for Communication
TOP